{
  "id": 14853866,
  "title": "United Therapeutics CEO Rothblatt sells $5.1m in shares",
  "url": "https://urgent.news/2026/10/16/united-therapeutics-ceo-rothblatt-sells-5-1m-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T02:46:19.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/united-therapeutics-ceo-rothblatt-sells-51m-in-shares-93CH-4952988"
  },
  "original_language": "en",
  "account": "On October 14, 2026, United Therapeutics Corp (NASDAQ:UTHR) Chairperson and CEO Martine A. Rothblatt sold around $5.1 million worth of the company's common stock. The shares were sold as part of a pre-planned 10b5-1 trading strategy adopted in November 2025. Shares were purchased at prices between $526.07 and $546.00, with a final value of $541.00 per share, bringing the biotechnology company's valuation to $23.2 billion. Despite Rothblatt's sale, the stock has gained 25% in value over the past year. The CEO also purchased 9,500 shares of United Therapeutics common stock through stock options, paying $117.76 per share, totaling $1,118,720. These options were exercised under the same trading plan and were vested in equal one-third installments on March 15, 2021, 2022, and 2023. Rothblatt indirectly holds a share of 333,410 shares of common stock and 233,410 stock options through family trusts. Recent news includes United Therapeutics reporting a revenue miss, leading to a price target reduction by BofA Securities, while Jefferies raised its price target.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Oruka Therapeutics CMO Joana Goncalves sells $523,647 in stock",
        "url": "https://urgent.news/2026/10/15/oruka-therapeutics-cmo-joana-goncalves-sells-523-647-in-stock",
        "published": "2026-10-15T22:46:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}